Premium
The Critical Path Initiative: Leveraging Collaborations to Enhance Regulatory Science
Author(s) -
Barratt R A,
Bowens S L,
McCune S K,
Johannessen J N,
Buckman S Y
Publication year - 2012
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1038/clpt.2011.318
Subject(s) - work (physics) , government (linguistics) , drug development , data sharing , space (punctuation) , new product development , path (computing) , product (mathematics) , regulatory science , business , knowledge management , engineering ethics , computer science , engineering management , engineering , medicine , pharmacology , drug , marketing , alternative medicine , mechanical engineering , philosophy , linguistics , geometry , mathematics , pathology , programming language , operating system
Since 2004, the Critical Path Initiative has prompted industry, academia, and government agencies to work together to share the information, technology, and expertise critical to modernize and transform our approach to drug development and review. Various collaborations have been sharing data in a precompetitive space, establishing data standards, and facilitating collective tool development. As a result, the organization is making progress toward developing knowledge and tools that can reduce uncertainty in medical product development. Clinical Pharmacology & Therapeutics (2012); 91 3, 380–383. doi: 10.1038/clpt.2011.318